Bank Of New York Mellon Corp Abb Vie Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

A detailed history of Bank Of New York Mellon Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 19,833,087 shares of ABBV stock, worth $3.2 Billion. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,833,087

Previous 22,104,491 10.28%

Holding current value

$3.2 Billion

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$159.82 - $182.1 $363 Million - $414 Million	-2,271,404 Reduced 10.28%	19,833,087 $0
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $241 Million - $271 Million	1,748,419 Added 8.59%	22,104,491 $0
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $47.1 Million - $54.6 Million	352,817 Added 1.76%	20,356,072 $0
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $24.5 Million - $30.5 Million	-184,804 Reduced 0.92%	20,003,255 $0
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $2.92 Billion - $3.36 Billion	20,188,059 New	20,188,059 $0

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $2.8 Billion - $3.36 Billion	20,242,129 New	20,242,129 $3.27 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $80.4 Million - $92.2 Million	-598,934 Reduced 2.81%	20,689,448 $2.78 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $204 Million - $259 Million	1,479,757 Added 7.47%	21,288,382 $3.26 Billion
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $208 Million - $258 Million	-1,576,202 Reduced 7.37%	19,808,625 $3.21 Billion
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $31.6 Million - $40 Million	294,359 Added 1.4%	21,384,827 $2.9 Billion
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $10.1 Million - $11.5 Million	94,954 Added 0.45%	21,090,468 $2.28 Billion
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $41.4 Million - $46.2 Million	393,894 Added 1.91%	20,995,514 $2.36 Billion
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $16.5 Million - $18.2 Million	-161,545 Reduced 0.78%	20,601,620 $2.23 Billion
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $22.1 Million - $29.8 Million	-274,114 Reduced 1.3%	20,763,165 $2.22 Billion
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $30.1 Million - $35.3 Million	-350,284 Reduced 1.64%	21,037,279 $1.84 Billion
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $205 Million - $275 Million	2,797,448 Added 15.05%	21,387,563 $2.1 Billion
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $224 Million - $340 Million	3,480,190 Added 23.03%	18,590,115 $1.42 Billion
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $48.9 Million - $61.2 Million	-678,062 Reduced 4.29%	15,109,925 $1.34 Billion
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $676,783 - $813,687	-10,746 Reduced 0.07%	15,787,987 $1.2 Billion
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $1.06 Million - $1.36 Million	-16,166 Reduced 0.1%	15,798,733 $1.15 Billion
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $8.22 Million - $9.67 Million	-106,534 Reduced 0.67%	15,814,899 $1.27 Billion
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $3.24 Million - $4 Million	41,680 Added 0.26%	15,921,433 $1.47 Billion
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $34 Million - $37.8 Million	382,597 Added 2.47%	15,879,753 $0
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $96.8 Million - $115 Million	-1,078,202 Reduced 6.5%	15,497,156 $1.44 Billion
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $15.4 Million - $20.6 Million	-167,259 Reduced 1.0%	16,575,358 $1.57 Billion
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $1.5 Billion - $1.64 Billion	16,742,617	16,742,617 $1.62 Billion

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account

Bank Of New York Mellon Corp Abb Vie Inc. Transaction History